Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-11-22
1991-09-24
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 530324, 530325, 530326, A61K 3702, C07K 708, C07K 710
Patent
active
050514032
ABSTRACT:
A method of reducing neuronal damage related to an ischemic condition in a human patient, such as stroke-induced damage, by administration of a binding/inhibitory omega-conotoxin peptide.
REFERENCES:
patent: 4447356 (1984-05-01), Olivera et al.
patent: 4925664 (1990-05-01), Jackson et al.
patent: 4950739 (1990-08-01), Cherksey et al.
Olivera et al., Science, vol. 230, (1985) pp. 1338-1343.
Gray et al., Ann. Rev. Biochem., 57 pp. 655-700 (1988).
Ahmad, S. et al., Brain Research, 453:247-256 (1988).
Anderson, A. J., et al., Neuroscience Letts., 82:177-180 (1987).
Bennett, J. P. et al., Neurotransmitter Receptor Binding, pp. 61-89, Raven Press, N.Y. (1983).
Chou, P. Y., Fasman, G. D. Biophysics J., 26, pp. 367-384 (1979).
Gray, W. R., et al., Ann. Rev. Biochem., 57, pp. 655-700 (1988).
Haley, T., et al., Brit. J. Pharmacol., 23, pp. 12-15 (1957).
Kessler, H., et al., Angew. Chim. Int. Eng. Ed., 27, pp. 490-536 (1988).
Kirino, T., Brain Research, 239, pp. 57-69 (1982).
McCleskey, E. W., et al. PNAS, 84, pp. 4327-4331 (1987).
Morel, N., Meunier, F-M., J. Neurochem., 36, pp. 1766-1773 (1981).
Olivera, B., et al., Science, 230, pp. 1338-1343 (1985).
Pulsinelli, W. A., et al., Stroke, 10, pp. 267-272 (1979).
Sano, K., et al., Eur. J. Pharmacol., 141, pp. 235-141 (1987).
Schweitzer, E., J. Neurosci., 7, pp. 2948-2956 (1987).
Tsien, R. W., et al., TINS, 11, pp. 431-438 (1988).
Van Reempts, J., et al., Acad. Anaesthesiolica Belge, 35, Suppl., pp. 209-218 (1984).
Wauquier, A. et al., Neuroscience and Biobehavioral Reviews, 11 pp. 287-306 (1987).
Yamaguchi, T., Klatzo, I., in Cerebral Ishemia, (Bes, A., Braquet, P., and Sisejo, B. K. eds.), Elsevier Sciences Publ., pp. 13-24 (1984).
Yamashiro, D., Int. J. Protein Peptide Res., 30, pp. 9-12 (1987).
Bean, B. P., Annu. Rev. Physiol. 51:367-84 (1989).
Choi, D. W., "Calcium-Mediated Neurotoxicity: Relationship to Specific Channel Types and Role in Ischemic Damage".
Greenberg, D. A., Curr. Neurol. 6:91-121 (1986).
Hossmann, K. -A, "Calcium Antagonists for the Treatment of Brain Ischemia: A Critical Appraisal".
Marqueze, Beatrice, et al., Molecular Pharmacology, 34:87-90.
Tateishi, A., et al., Stroke 20:1044-1050 (1989).
Vibulsreth, S., et al., "Failure of Nimodipine to Prevent Ischemic Neuronal Damage in Rats.".
Bitner Robert S.
Bowersox Stephen S.
Fox James A.
Miljanich George P.
Valentino Karen L.
Davenport Avis M.
Dehlinger Peter J.
Lee Lester L.
Neurex Corporation
LandOfFree
Method of treating ischemia-related neuronal damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating ischemia-related neuronal damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating ischemia-related neuronal damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1696679